DD148053A5 - Verfahren zur herstellung neuer n-substituierter trifluorethylamine - Google Patents

Verfahren zur herstellung neuer n-substituierter trifluorethylamine Download PDF

Info

Publication number
DD148053A5
DD148053A5 DD79217855A DD21785579A DD148053A5 DD 148053 A5 DD148053 A5 DD 148053A5 DD 79217855 A DD79217855 A DD 79217855A DD 21785579 A DD21785579 A DD 21785579A DD 148053 A5 DD148053 A5 DD 148053A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
acid
previously defined
trifluoromethyl
salt
Prior art date
Application number
DD79217855A
Other languages
German (de)
English (en)
Inventor
Charles Malen
Pierre Roger
Michel Laubie
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of DD148053A5 publication Critical patent/DD148053A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/16Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • C07C49/167Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing only fluorine as halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29Saturated compounds containing keto groups bound to rings
    • C07C49/327Saturated compounds containing keto groups bound to rings containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD79217855A 1978-12-20 1979-12-19 Verfahren zur herstellung neuer n-substituierter trifluorethylamine DD148053A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7835741A FR2444673A1 (fr) 1978-12-20 1978-12-20 Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
DD148053A5 true DD148053A5 (de) 1981-05-06

Family

ID=9216327

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79217855A DD148053A5 (de) 1978-12-20 1979-12-19 Verfahren zur herstellung neuer n-substituierter trifluorethylamine

Country Status (16)

Country Link
US (1) US4378366A (xx)
JP (1) JPS5846516B2 (xx)
AR (1) AR223997A1 (xx)
AU (1) AU5399879A (xx)
BE (1) BE880743A (xx)
CA (1) CA1169859A (xx)
DD (1) DD148053A5 (xx)
DE (1) DE2951247A1 (xx)
ES (1) ES487148A0 (xx)
FR (1) FR2444673A1 (xx)
GB (1) GB2044756B (xx)
IL (1) IL59002A0 (xx)
IT (1) IT1164915B (xx)
NL (1) NL7909200A (xx)
OA (1) OA06415A (xx)
ZA (1) ZA796884B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3417411A1 (de) * 1983-06-30 1985-01-03 Canon K.K., Tokio/Tokyo Tintenherstellungssystem
US4802989A (en) * 1983-07-28 1989-02-07 Canon Kabushiki Kaisha System for purifying dye
DK302185A (da) * 1984-07-05 1986-01-06 Rolland Sa A 2-amino-oxazoliner samt fremgangsmaade til deres fremstilling
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
US6265616B1 (en) * 1999-02-08 2001-07-24 Honeywell International Inc. Manufacture of trifluorisopropylamine
US6297384B1 (en) 1999-12-21 2001-10-02 The Procter & Gamble Company Process for the preparation of 1,2,4-thiadiazoles
JP2005161674A (ja) * 2003-12-02 2005-06-23 Canon Inc 画像形成装置、画像形成システム、課金処理方法及びプログラム
JP5902575B2 (ja) * 2012-07-20 2016-04-13 国立大学法人お茶の水女子大学 光学活性含フッ素アミン化合物の製造方法並びに光学活性含フッ素アミン化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670754A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylimino-oxazolidinen
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
DE1670753A1 (de) * 1966-09-27 1970-07-16 Bayer Ag Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen
DE1670752A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-oxazolinen
DE2253554C3 (de) * 1972-11-02 1981-02-12 Hoechst Ag, 6000 Frankfurt 2-Amino-2-oxazoline, Verfahren zu ihrer Herstellung und deren Verwendung zur Erhöhung des Blutdrucks
GB1453703A (en) * 1972-12-28 1976-10-27 Science Union & Cie Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them
US4102890A (en) * 1972-12-28 1978-07-25 Science-Union Et Cie, Societe Francaise De Recherche Medicale 2-Amino oxazolines and process for making the same
GB1475513A (en) * 1974-06-20 1977-06-01 Science Union & Cie Benzylamine derivatives process for science union et cie benzylamine derivatives process for their production and pharmaceutical compositions containing them
ES442992A1 (es) * 1974-12-02 1977-08-01 Scherico Ltd Un procedimiento para preparar 2-anilino-oxazolinas.
FR2358890A1 (fr) * 1976-05-24 1978-02-17 Science Union & Cie Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
DE2710170A1 (de) * 1977-03-09 1978-09-14 Byk Gulden Lomberg Chem Fab Neue geminal substituierte cycloalkane, verfahren zu deren herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
DE2951247A1 (de) 1980-07-03
OA06415A (fr) 1981-09-30
GB2044756A (en) 1980-10-22
FR2444673A1 (fr) 1980-07-18
DE2951247C2 (xx) 1988-03-10
AU5399879A (en) 1980-06-26
ZA796884B (en) 1980-11-26
AR223997A1 (es) 1981-10-15
IT7951130A0 (it) 1979-12-19
ES8101567A1 (es) 1980-12-16
US4378366A (en) 1983-03-29
FR2444673B1 (xx) 1981-04-17
BE880743A (fr) 1980-06-19
GB2044756B (en) 1982-12-22
CA1169859A (fr) 1984-06-26
NL7909200A (nl) 1980-06-24
IL59002A0 (en) 1980-03-31
JPS5592373A (en) 1980-07-12
JPS5846516B2 (ja) 1983-10-17
ES487148A0 (es) 1980-12-16
IT1164915B (it) 1987-04-15

Similar Documents

Publication Publication Date Title
DE69316377T2 (de) Serotoninrezeptor-mittel
DE3218584C2 (xx)
DE2734070C2 (de) Aminoalkylfuranderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2322880C2 (de) 4-(Imidazolin-2-ylamino)-2,1,3-benzothiadiazole und Verfahren zu deren Herstellung
DE2238504B2 (de) l-Phenoxy-3-alkylaminopropan-2-ol -Derivate
DD148053A5 (de) Verfahren zur herstellung neuer n-substituierter trifluorethylamine
DE3445339C2 (xx)
DE1670772C3 (de) 4H-3,1-Benzoxazin-Derivate, deren Salze und pharmazeutische Präparate
DE1620449B2 (de) Substituierte benzimidazole und verfahren zu ihrer herstellung
DE2723464A1 (de) Aryltrifluoraethylamine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2362754A1 (de) Cyclopropylmethylamine, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE2361188A1 (de) Bicyclische imidazole und pyrimidine, verfahren zu ihrer herstellung und arzneimittel
DE3233424A1 (de) Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
DE3305495A1 (de) Piperazin- und homopiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE69012451T2 (de) Cyanoguanidin-Derivate.
DE69011714T2 (de) Kalziumantagonisten.
DE2656227C2 (de) Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE1670020A1 (de) Substituierte Piperidine und Verfahren zu ihrer Herstellung
DE2949395A1 (de) Verwendung von substituierten chinazolinen zur behandlung von hochdruck und bradykardie sowie als kardiotone wirkstoffe
DE69901522T2 (de) Benzozyclobutanverbindungen, deren Herstellungsverfahren und diese enthaltende pharmazeutische Zusammenstellungen
DE1670143C3 (xx)
DE2949971C2 (de) 2-Phenylamino-2-imidazolin-Derivate mit besonderen therapeutischen Eigenschaften, Verfahren zu ihrer Herstellung und Arzneimittel mit einem Gehalt dieser Verbindungen
DE69619861T2 (de) 3-(2h)-pyridazinon derivate und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE1695092B2 (de) N-(4-Sulfonamidophenyl)-a-alkylsuccinimide und deren Salze mit Basen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE1962149A1 (de) Organische Verbindungen und Verfahren zu ihrer Herstellung